Skip to content

The Effect of Dual Tasking on Physical and Cognitive Functions in Patients With Parkinson Disease

Effects of Dual Task Training And Treadmill Training on Physical and Cognitive Functions in Patients With Parkinson Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03902990
Enrollment
45
Registered
2019-04-04
Start date
2018-10-01
Completion date
2019-04-01
Last updated
2019-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Keywords

dual task, treadmill, cognitive rehabilitation

Brief summary

The ability of performing multi-tasking procedures is impaired in patients with Parkinson's disease. In this study, our goal was to detect the effects of dual-task training with treadmill training on walking and balance and to compare its effects on quality of life, cognitive functions and risk of fall, to treadmill training alone.

Interventions

OTHERDual task

The patients in the dual task group received cognitive tasks during treadmill training sessions.

OTHERTreadmill Training

Standard treadmill training

OTHERStandard exercise programme

Standard exercise programme for Parkinson Disease

Sponsors

Istanbul University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Intervention model description

In this prospective, randomized, controlled, double-blinded study the patients were randomized to three groups as; dual-task group, single-task group and control group. All of the patients were scheduled on standard exercise programme. The patients in dual-task group received treadmill training with cognitive tasks and the patients in single-task group received treadmill training alone in addition to standard exercise programme. The training was scheduled as 30 minute sessions under supervision of a specialist, three times in a week for four weeks.

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

The patients with Idiopathic Parkinson Disease on medication who has * Hoehn-Yahr 1-3 * Mini Mental Test score 20 and above * Functional Ambulation Category 2 and above * No changes in medication in last 3 months * No rehabilitation programme in last 3 months

Exclusion criteria

* Diagnosis of Parkinsonism other than Idiopathic Parkinson Disease * Global aphasia * Severe cognitive dysfunction * Other neurologic/orthopedic diseases * Limiting cardiovascular or pulmonary disease * Visual impairment * Hearing loss

Design outcomes

Primary

MeasureTime frameDescription
10MWT12 weeks10 Meter Walk Test on comfortable speed
10MWT with cognitive tasks12 weeks10 Meter Walk Test with cognitive tasks
MoCA12 weeksMontreal Cognitive Assessment
TUG12 weeksTimed Up and Go Test

Secondary

MeasureTime frameDescription
PDQ-3912 weeksParkinson Disease Questionnaire 39
Falls Diary4 weeksFalls account
FES-I12 weeksTo evaluate fear of falling, all patients filled the Falls Efficacy Scale-International (FES-I). A series of 16 questions assesses the respondent's fear of falling for a range of ADLs. Each question was rated on a four-point scale.
Stroop Test12 weeksCognitive assessment for executive functions
FOGQ12 weeksFreezing of Gait Questionnaire

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026